DIER MARDI (EVP and CFO) sold 28.6% of their position (4.17K shares) of MADRIGAL PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $2.41M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+4.17K
Price / share
$251.63
Trade value
$1.05M
% of position
Common Stock
Shares
−320.00
Price / share
$570.39
Trade value
$182.52K
% of position
Common Stock
Shares
−410.00
Price / share
$571.99
Trade value
$234.52K
% of position
Common Stock
Shares
−354.00
Price / share
$573.02
Trade value
$202.85K
% of position
Common Stock
Shares
−717.00
Price / share
$574.00
Trade value
$411.56K
% of position
Common Stock
Shares
−120.00
Price / share
$574.95
Trade value
$68.99K
% of position
Common Stock
Shares
−240.00
Price / share
$576.15
Trade value
$138.28K
% of position
Common Stock
Shares
−320.00
Price / share
$577.81
Trade value
$184.90K
% of position
Common Stock
Shares
−258.00
Price / share
$578.83
Trade value
$149.34K
% of position
Common Stock
Shares
−480.00
Price / share
$579.85
Trade value
$278.33K
% of position
Common Stock
Shares
−240.00
Price / share
$585.44
Trade value
$140.51K
% of position
Common Stock
Shares
−240.00
Price / share
$587.85
Trade value
$141.08K
% of position
Common Stock
Shares
−160.00
Price / share
$589.65
Trade value
$94.34K
% of position
Common Stock
Shares
−160.00
Price / share
$590.37
Trade value
$94.46K
% of position
Common Stock
Shares
−74.00
Price / share
$595.20
Trade value
$44.05K
% of position
Common Stock
Shares
−80.00
Price / share
$596.18
Trade value
$47.69K
% of position
Net shares
+0.00
Net value
-$1.36M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/2/2025 | M · Option Exercise | +4.17K | $251.63 | $1.05M | 40.0% | 10.44K | 14.61K |
| Common Stock Direct | 12/2/2025 | S · Sale | −320.00 | $570.39 | $182.52K | 2.2% | 14.61K | 14.29K |
| Common Stock Direct | 12/2/2025 | S · Sale | −410.00 | $571.99 | $234.52K | 2.9% | 14.29K | 13.88K |
| Common Stock Direct | 12/2/2025 | S · Sale | −354.00 | $573.02 | $202.85K | 2.5% | 13.88K | 13.53K |
| Common Stock Direct | 12/2/2025 | S · Sale | −717.00 | $574.00 | $411.56K | 5.3% | 13.53K | 12.81K |
| Common Stock Direct | 12/2/2025 | S · Sale | −120.00 | $574.95 | $68.99K | 0.9% | 12.81K | 12.69K |
| Common Stock Direct | 12/2/2025 | S · Sale | −240.00 | $576.15 | $138.28K | 1.9% | 12.69K | 12.45K |
| Common Stock Direct | 12/2/2025 | S · Sale | −320.00 | $577.81 | $184.90K | 2.6% | 12.45K | 12.13K |
| Common Stock Direct | 12/2/2025 | S · Sale | −258.00 | $578.83 | $149.34K | 2.1% | 12.13K | 11.87K |
| Common Stock Direct | 12/2/2025 | S · Sale | −480.00 | $579.85 | $278.33K | 4.0% | 11.87K | 11.39K |
| Common Stock Direct | 12/2/2025 | S · Sale | −240.00 | $585.44 | $140.51K | 2.1% | 11.39K | 11.15K |
| Common Stock Direct | 12/2/2025 | S · Sale | −240.00 | $587.85 | $141.08K | 2.2% | 11.15K | 10.91K |
| Common Stock Direct | 12/2/2025 | S · Sale | −160.00 | $589.65 | $94.34K | 1.5% | 10.91K | 10.75K |
| Common Stock Direct | 12/2/2025 | S · Sale | −160.00 | $590.37 | $94.46K | 1.5% | 10.75K | 10.59K |
| Common Stock Direct | 12/2/2025 | S · Sale | −74.00 | $595.20 | $44.05K | 0.7% | 10.59K | 10.52K |
| Common Stock Direct | 12/2/2025 | S · Sale | −80.00 | $596.18 | $47.69K | 0.8% | 10.52K | 10.44K |
| Total | +0.00 | -$1.36M | ||||||
Stock Option (Right to Buy)
Common Stock
4.17K shares
Shares
−4.17K
Strike price
251.63
Held after
9.18K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock4.17K shares | 12/2/2025 | M · Option Exercise | −4.17K | 251.63 | — | 9.18K |